Assessment & Research

Parent report of antidepressant, anxiolytic, and antipsychotic medication use in individuals with Williams syndrome: effectiveness and adverse effects.

Martens et al. (2012) · Research in developmental disabilities 2012
★ The Verdict

Parents say fluoxetine, sertraline, risperidone, and quetiapine help anxiety and behavior in Williams syndrome, while paroxetine and aripiprazole fall short.

✓ Read this if BCBAs working with Williams syndrome in clinic or school settings
✗ Skip if Practitioners who only serve clients with ASD or ADHD and rarely see genetic syndromes

01Research in Context

01

What this study did

The team sent a short survey to parents of people with Williams syndrome. Parents listed every antidepressant, anxiety, or antipsychotic drug their child had tried. They also rated how well each drug worked and what side effects showed up.

The survey asked about common drugs like fluoxetine, risperidone, and aripiprazole. The goal was to see which medicines parents found helpful and which ones caused problems.

02

What they found

Parents said SSRIs such as fluoxetine and sertraline usually eased anxiety and improved behavior. Risperidone and quetiapine also earned good marks for calming irritability.

Paroxetine and aripiprazole scored lower. Parents reported more unwanted movements or no clear benefit with these two drugs. Most side effects were mild and involved sleep or muscle stiffness.

03

How this fits with other research

Schaaf et al. (2015) used the same survey style across four syndromes. They found parents often report fewer diagnoses and prescriptions than research papers claim. The Williams-only data in Storch et al. (2012) fits that pattern: helpful drugs are used, yet some children who might benefit still go without.

Rasmussen et al. (2019) counted psychotropic use in Australian children with autism. One third had at least one prescription. The Williams survey mirrors this real-world snapshot, showing antidepressants and antipsychotics are common outside autism too.

Dwyer et al. (2025) and McQuaid et al. (2024) asked Angelman parents about behavior and family stress, not pills. Their work reminds us that drug choices matter because irritability and stereotypy weigh heavily on families. The Williams survey gives parents a voice on which pills lighten that load.

04

Why it matters

If you serve a client with Williams syndrome, ask the family which psychotropic drugs they have tried and how they rated them. Use their history to guide future decisions. When starting an SSRI or risperidone, set clear behavior targets and track side effects weekly. Share the parent-friendly summary from this paper so caregivers know their experience lines up with other families and is worth reporting to the prescriber.

Free CEUs

Want CEUs on This Topic?

The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.

Join Free →
→ Action — try this Monday

Add one question to your intake form: 'List all current psychotropic meds and mark any that helped or caused side effects.'

02At a glance

Intervention
not applicable
Design
survey
Sample size
513
Population
other
Finding
positive
Magnitude
medium

03Original abstract

Williams syndrome (WS) is a neurodevelopmental genetic disorder characterized in part by anxiety and behavioral difficulties. We examine the effectiveness and adverse effects of antidepressant, anxiolytic, and antipsychotic medications in individuals with WS. A total of 513 parents/caregivers completed a survey of psychotropic medication usage regarding their child or adult with WS. Twenty-four percent (24%) of the individuals had been prescribed an SSRI medication, while 12% had been prescribed another type of antidepressant or anxiolytic. Overall, 81% of respondents indicated that SSRI medications were either "Helpful" or "Somewhat Helpful", with paroxetine reported to be the least helpful. Sixty-four percent (64%) of survey participants reported that non-SSRI antidepressants and anxiolytics were either "Helpful" or "Somewhat Helpful" in treating symptoms of anxiety. Side effects for the antidepressants and anxiolytics were typically neurological in nature. Ten percent (10%) of the survey participants reported taking an antipsychotic medication, with risperidone and quetiapine described as more helpful than aripiprazole. Medication effectiveness may be related to the impact on serotonin levels. These findings call for further studies of medication usage in WS in order to improve their quality of life.

Research in developmental disabilities, 2012 · doi:10.1016/j.ridd.2012.06.006